Health Products

Bortezomib for Injection (2018-04-18)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
9501016Bortezomib for Injection
Recalling Firm
Teva Canada Inc. 30 Novopharm Court Toronto, Ontario M1B 2K9
Marketing Authorization Holder
Teva Canada Inc. 30 Novopharm Court Toronto, Ontario M1B 2K9
Powder for solutionDIN 02423405Bortezomib, 3.5mg/vial

Introduction

Affected Products

Bortezomib for Injection

Reason

Potential for presence of particulate matter (glass) in affected lot.

Depth of distribution

Wholesalers, retailers and healthcare establishments (BC, SK, MB, ON, Que, NS, Nfld)
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime